All stock lists
Roivant Sciences Ltd. (NASDAQ:ROIV)
GB · Delayed Price · Currency is USD
Healthcare · Biotechnology
36.00-0.49 (-1.33%)
Insider Score
––Not scored
ROIV Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ROIV analyst forecast
ROIV analyst consensus
No analyst ratings in the last 3 months.
ROIV 12-month price target
$46.00+28.8% upsideaverage of 1 firm
$46.00High
$46.00Low
Best analysts covering ROIV
No firm covering ROIV has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ROIV analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Guggenheim | — | $46.00 | +10.9% | — | 2026-09-09 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.